A randomized, phase III trial of capecitabine plus bevacizumab (Cape-Bev) versus capecitabine plus irinotecan plus bevacizumab (CAPIRI-Bev) in first-line treatment of metastatic colorectal cancer: the AIO KRK 0110 trial/ML22011 trial
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Sebastian Stintzing Ursula Vehling-Kaiser Julia Mayerle Ludwig Fischer von Weikersthal |
| Publication date | August 23, 2011 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |